Primary Esophageal Lymphoma: A Histopathological Experience from Two Tertiary Hospitals, Western Saudi Arabia by Jaudah Al-Maghrabi, Sahar Al-Maghrabi

“…None of the patients were immunocompromised or had human immunodeficiency virus (HIV) infection. The clinical manifestation included dysphagia and loss of weight. …”
Get full text

The critical role of primary care clinicians in the early detection of ocular surface squamous neoplasia by Leendert Dekker, Jan F. Olivier, Klaus von Pressentin

“…Its rising incidence, primarily driven by the human immunodeficiency virus (HIV) epidemic, presents significant challenges in clinical diagnosis, as these lesions often share characteristics with other conjunctival lesions. …”
Get full text

The occupational roles of hospitalized people due to Acquired Immune Deficiency Syndrome by Natália Augusto Nunes Gil, Marysia Mara Rodrigues do Prado De Carlo

“…Persons hosting Human Immunodeficiency Virus (HIV) and patients having Acquired Immunodeficiency Syndrome (AIDS) suffer from alterations of occupational roles. …”
Get full text

Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered Ivermectin by Charles E. Rose, Christopher A. Paciullo, David R. Kelly, Mark J. Dougherty, Lawrence L. Fleckenstein

“…Those people most susceptible to infection are those with an immunocompromising condition, such as cancer or human immunodeficiency virus (HIV). Local disease may spread throughout the body of the host, causing a condition termed disseminated strongyloidiasis. …”
Get full text

Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review by Robert Root-Bernstein

“… Few people exposed to human immunodeficiency virus (HIV) become infected. Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral therapies (ARTs). …”
Get full text

Extensive Inactive Neurocysticercosis: A Case Report in Mbeya, Southern Highlands of Tanzania by Makasi CE, Ngowi BJ, Stelzle D, Kilale AM, Mahande MJ, Welte TM, Winkler AS, Mmbaga BT

“…So far, little is known about how Human Immunodeficiency Virus (HIV) co-infection modifies clinical NCC presentation. …”
Get full text

Analysis of HIV therapy in the liver using optimal control and pharmacokinetics by Hasifa Nampala, Matylda Jabłońska-Sabuka, Martin Singull

“…Abstract The main burden in treating human immunodeficiency virus (HIV) infection currently, is the side effects of the antiretroviral therapy (ART) used, because each treatment is toxic to the liver. …”
Get full text

Pneumocystis carinii: A Review of an Important Opportunistic Pathogen in AIDS by M John Gill, Ron Read

“…Individuals with damaged T helper cells secondary to malignancies (eg, Hodgkin’s lymphoma), drugs (eg, cyclosporine, steroids), or certain infections (eg, human immunodeficiency virus) are at particular risk. Serological studies suggest that disease is most often secondary to the reactivation of an asymptomatic infection, usually acquired during childhood. …”
Get full text

HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies by Tingxia Lv, Wei Cao, Taisheng Li

“…Although antiretroviral therapy effectively controls human immunodeficiency virus (HIV) replication, a residual chronic immune activation/inflammation persists throughout the disease. …”
Get full text

Autoimmune Hepatitis (AIH) in Acquired Immune Deficiency Syndrome (AIDS): A Case Report and Review of Literature by Jordan Roussel, Sudha Pandit, Paul Jordan, Moheb Boktor, Kurt Knowles, Nester Dela Cruz, Hrishikesh Samant

“…The common causes of abnormal liver chemistries in human immunodeficiency virus (HIV) infected patients are multifactorial. …”
Get full text

Key characteristics in designing HIV interventions at a glance by Mona Larki, Elham Manouchehri

“…Worldwide commitments to reduce AIDS-related mortality and new human immunodeficiency virus (HIV) infections to under 500,000 by the end of 2020 failed last year, as 680,000 people have died from AIDS-related diseases and 1.5 million have become infected with HIV. …”
Get full text

Treatment of Recurrent Primary Cutaneous Mucinous Carcinoma of the Eyelid with Modified Wide Local Excision by Stephanie M. Tillit, Siva S. R. Iyer, Eric J. Grieser, John T. LiVecchi

“…This report presents the first case in the literature of primary cutaneous mucinous carcinoma in a patient with human immunodeficiency virus (HIV). With this case report, we aim to raise awareness of primary cutaneous mucinous carcinoma as a potential part of the differential diagnosis for malignant eyelid lesions, including those present in patients with HIV.…”
Get full text

Risk Factors for Tuberculosis by Padmanesan Narasimhan, James Wood, Chandini Raina MacIntyre, Dilip Mathai

“…Along with well-established risk factors (such as human immunodeficiency virus (HIV), malnutrition, and young age), emerging variables such as diabetes, indoor air pollution, alcohol, use of immunosuppressive drugs, and tobacco smoke play a significant role at both the individual and population level. …”
Get full text

Extended Peritoneal Dialysis and Renal Recovery in HIV-Infected Patients with Prolonged AKI: A Report of 2 Cases by Donlawat Saengpanit, Pongpratch Puapatanakul, Piyaporn Towannang, Talerngsak Kanjanabuch

“…Moreover, the setting of human immunodeficiency virus- (HIV-) infected patients with AKI requiring RRT makes the decision on RRT initiation and modality selection more complicated. …”
Get full text

RNA Viruses: ROS-Mediated Cell Death by Mohammad Latif Reshi, Yi-Che Su, Jiann-Ruey Hong

“…This review focuses on RNA viruses and retroviruses, giving particular attention to the human influenza virus, Hepatitis c virus (HCV), human immunodeficiency virus (HIV), and the aquatic Betanodavirus. …”
Get full text

Topical Microbicides for the Prevention of Sexually Transmitted Diseases and HIV by André Désormeaux, Rabeea F Omar, Michel G Bergeron

“…The development of novel compounds to reduce the sexual transmission of human immunodeficiency virus (HIV), herpes and other pathogens causing sexually transmitted diseases (STDs) has become a topic of great interest. …”
Get full text

Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain by Geeta Ramesh, Andrew G. MacLean, Mario T. Philipp

“…This review will focus on how cytokines and chemokines affect neuroinflammation and disease pathogenesis in bacterial meningitis and brain abscesses, Lyme neuroborreliosis, human immunodeficiency virus encephalitis, and neuropathic pain.…”
Get full text

Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis by Abigayle Sullivan, Theresa Lanham, Ronald Krol, Shilla Zachariah

“…We describe a rare case of Pneumocystis jirovecii pneumonia (PCP) in a heterosexual man with a pertinent medical history of well-controlled human immunodeficiency virus (HIV) on highly active antiretroviral therapy (HAART) and PCP prophylaxis with atovaquone. …”
Get full text

T Cell Activation and Regulation of HIV-1: Same Effectors with Distinct Outcomes by Jean-François Fortin, Benoit Barbeau, Gilles A Robichaud, Michel J Tremblay

“…The molecular mechanisms that regulate the function of the immune system and human immunodeficiency virus type-1 (HIV-1) gene expression are diverse and complicated. …”
Get full text

Structural insights into HIV-2 CA lattice formation and FG-pocket binding revealed by single-particle cryo-EM by Matthew Cook, Christian Freniere, Chunxiang Wu, Faith Lozano, Yong Xiong

“…Summary: One of the striking features of human immunodeficiency virus (HIV) is the capsid, a fullerene cone comprised of pleomorphic capsid protein (CA) that shields the viral genome and recruits cofactors. …”
Get full text